Thiodiglycolic anhydride - ≥98% , CAS No.3261-87-8

CAS: 3261-87-8 Cat. No.: T136548 Peso molecular: 132.13 Beilstein Registry Number: 112528 Número EC: 608-761-6 PubChem CID: 137871
Disponible para pedir
GRADE & PURITY ≥98%
Synonyms
AKOS008988060 | RIIUAPMWDSRBSH-UHFFFAOYSA-N | Thiodiglycolic anhydride, AldrichCPR | DTXSID30186306 | Thiodiglycolic anhydride | FT-0634751 | H10798 | C4H4O3S | 1-Oxa-4-thia-cyclohexan-2,6-dione | 1,4-Oxathiane-2,6-dione # | STR03033 | MFCD00051689 | 1,4-
Storage
Room temperature,Argon charged
Shipped In
Normal
 ·  off list, applied to all prices below.
Size
Estado
Price
Qty
1g
T136548-1g
2
9,90US$
5g
T136548-5g
2
10,90US$
10g
T136548-10g
3
11,90US$
25g
T136548-25g
2
12,90US$
100g
T136548-100g
2
38,90US$
500g
T136548-500g
1
143,90US$
Enter a quantity for the sizes you want to add.
🧪

Why this grade

≥98% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Room temperature,Argon charged Ships Normal Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 9 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Specifications

Sinónimos
AKOS008988060 | RIIUAPMWDSRBSH-UHFFFAOYSA-N | Thiodiglycolic anhydride, AldrichCPR | DTXSID30186306 | Thiodiglycolic anhydride | FT-0634751 | H10798 | C4H4O3S | 1-Oxa-4-thia-cyclohexan-2, 6-dione | 1, 4-Oxathiane-2, 6-dione # | STR03033 | MFCD00051689 | 1, 4-
Especificaciones y pureza
≥98%
Condiciones de almacenamiento de almacenamiento
Room temperature, Argon charged
Enviado en
Normal
Pureza
≥98%
Nombres e identificadores
Pubchem Sid504757139
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/504757139
Sonrisas canónicasC1C(=O)OC(=O)CS1
IUPAC Name1,4-oxathiane-2,6-dione
InChIKeyRIIUAPMWDSRBSH-UHFFFAOYSA-N
INCHI1S/C4H4O3S/c5-3-1-8-2-4(6)7-3/h1-2H2
Isómeros SMILES C1C(=O)OC(=O)CS1
PubChem CID 137871
Peso molecular 132.13
Beilstein 112528

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
ClaseOxathianes
SubclassNot available
Intermediate Tree Nodes Not available
Direct ParentOxathianes
Alternative Parents Dicarboxylic acids and derivatives  Carboxylic acid anhydrides  Oxacyclic compounds  Dialkylthioethers  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  
Molecular FrameworkAliphatic heteromonocyclic compounds
Substituents 1,4-oxathiane - Dicarboxylic acid or derivatives - Carboxylic acid anhydride - Oxacycle - Dialkylthioether - Thioether - Carboxylic acid derivative - Organic oxygen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Carbonyl group - Aliphatic heteromonocyclic compound
DescripciónThis compound belongs to the class of organic compounds known as oxathianes. These are compounds containing an oxathiane moiety, which consists of a saturated aliphatic six-member ring with one oxygen atom, a sulfur atom, and four carbon atoms. Isomers of oxaphospholane include 1,2-oxathiane, 1,3-oxathiane,and 1,4-oxathiane.
External Descriptors Not available
Estructura 3D
Modelo de Estructura Química Interactiva





Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

15 results found

Lot NumberCertificate TypeFechaArticulo
K2218124Certificate of AnalysisJun 09, 2026 T136548
F2612519Certificate of AnalysisJun 04, 2026 T136548
F2612520Certificate of AnalysisJun 04, 2026 T136548
F2612521Certificate of AnalysisJun 04, 2026 T136548
F2612538Certificate of AnalysisJun 04, 2026 T136548
G1919264Certificate of AnalysisAug 15, 2025 T136548
K2113387Certificate of AnalysisMay 15, 2025 T136548
K2113389Certificate of AnalysisMay 15, 2025 T136548
A2509086Certificate of AnalysisJan 16, 2025 T136548
L2525114Certificate of AnalysisJan 16, 2025 T136548
A2509085Certificate of AnalysisJan 16, 2025 T136548
A2510628Certificate of AnalysisJan 04, 2025 T136548
L2427144Certificate of AnalysisJan 04, 2025 T136548
K2113388Certificate of AnalysisAug 18, 2023 T136548
K2113390Certificate of AnalysisAug 18, 2023 T136548

Show more ⌵

Propiedades químicas y físicas
SensibilidadHygroscopic,Air Sensitive
Punto de fusión (°C)95-100°
Peso molecular132.140 g/mol
XLogP30.400
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count0
Exact Mass131.988 Da
Monoisotopic Mass131.988 Da
Topological Polar Surface Area68.700 Ų
Heavy Atom Count8
Formal Charge0
Complexity117.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Citations of This Product
Referencias
1. Jianpeng Qin, Meng Sun, Yanli Zhen, Ji Li, Dongkai Wang.  (2023)  A ROS-response hyaluronic acid-coated/chitosan polymer prodrug for enhanced tumour targeting efficacy of SN38.  JOURNAL OF DRUG TARGETING,      [PMID:37216422] [10.1080/1061186X.2023.2216401]
2. Haiting Xu, Linxin Dai, Wenbiao Nie, Ruifeng Luo, Xiulan Pu, Lingling Dong, Qiyan Chen, Shanshan Qi, Xiaoqin Han, Jieshu You, Jinming Zhang, Fei Gao.  (2023)  Oral cyclodextrin supramolecular for ulcerative colitis treatment through macrophages targeting / ROS response-based accurate on-demand drug release strategy.  MATERIALS & DESIGN,      [PMID:] [10.1016/j.matdes.2023.111606]
3. Ruifeng Wu, Zhiqiang Zhang, Baohua Wang, Ge Chen, Yaozhong Zhang, Haowen Deng, Zilong Tang, Junjie Mao, Lei Wang.  (2022)  Combination Chemotherapy of Lung Cancer – Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid–Polymer Hybrid Nanoparticles.  Drug Design Development and Therapy,      [PMID:32606595] [10.2147/DDDT.S246574]
4. Wenfeng Xue, Ronghao Liu, Xiaoxia Liu, Yangyang Wang, Ping Lv, Yanzhao Yang.  (2022)  Selective extraction of Nd(III) by novel carboxylic acid based ionic liquids without diluent from waste NdFeB magnets.  JOURNAL OF MOLECULAR LIQUIDS,      [PMID:] [10.1016/j.molliq.2022.119919]
5. Hui Yan, Danping Wang, Chengyin Tian, Long Zhao, Yong Wang, Guoqing Long, Bingjun Sun, Jingming Jia, Anhua Wang.  (2024)  Elaboration a ROS-responsive darutigenol prodrug nanoassemblies for inflammatory arthritis treatment.  Nano Today,      [PMID:] [10.1016/j.nantod.2024.102220]
6. Jiayu Guo, Xiaoxiao Zhang, Fudan Dong, Simeng Wang, Danping Wang, Yaqiao Li, Shiyi Zuo, Qing Wang, Wenxiao Li, Jin Sun, Zhonggui He, Tianhong Zhang, Qikun Jiang, Bingjun Sun.  (2024)  Revealing the impact of modified modules flexibility on gemcitabine prodrug nanoassemblies for effective cancer therapy.  JOURNAL OF COLLOID AND INTERFACE SCIENCE,      [PMID:39128288] [10.1016/j.jcis.2024.08.026]
7. Ningcheng Wei, Yi Xiao, Yang Jin, Liying Zhang, Panpan Chen, Shuhu Du.  (2025)  Thioether-bridged carbon dots-dopamine quinone conjugate probe for glutathione sensing and discrimination between glioblastoma and normal cells.  TALANTA,      [PMID:40334510] [10.1016/j.talanta.2025.128249]
8. Li He, Jiao-Jiao Ma, Yi-Qun Wu, Chen-Guang Wang, Tong Lan, Lu Su, Lin Zhu, Shi-Wen Huang, Kai Deng, Yong-Chang Wei.  (2025)  X-ray stimulates NQO1-dependent cascade reactions to induce strong immunogenicity for MRI-guided cancer radio-chemodynamic-immunotherapy.  Theranostics,  15  (14): (6768).  [PMID:40585976] [10.7150/thno.110573]
9. Yunfan Li, Kaiwen Bao, Renzheng Huan, Tian Wang, Ya Wang, Shuai Wu, Xin Chen, Jiashang Huang, Li Zhu, Jianshu Li, Haifeng Yang, Wei Wu.  (2026)  RAP-peptide functionalized biomimetic nanoformulation with pathological ROS/pH-responsive drug release for target immunotherapy in glioma.  JOURNAL OF NANOBIOTECHNOLOGY,      [PMID:41654805] [10.1186/s12951-026-04055-4]
Calculadoras de soluciones
Reseñas

Reseñas de cliente

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.